Zhejiang Shouxiangu Pharmaceutical (603896.SH) has completed the filing of domestic health food for "Shouxiangu Hanfang brand broken ganoderma spore powder".
Shouxian Valley (603896.SH) announced that recently, its wholly-owned subsidiary, Jinhua Shouxian Valley Pharmaceutical Co., Ltd. ...
Zhejiang Shouxiangu Pharmaceutical (603896.SH) announced that its wholly-owned subsidiary, Jinhua Zhejiang Shouxiangu Pharmaceutical Co., Ltd., has completed the filing for domestic health food registration for its "Shouxian Hanfang Brand Broken Wall Lingzhi Spore Powder" product. The subsidiary has obtained the domestic health food filing certificate issued by the Zhejiang Provincial Market Supervision Administration.
The successful filing of the above-mentioned product will not have a significant impact on the company's current production and operation. However, it will be beneficial for further supplementing and improving the company's product categories, enriching the company's product line, and enhancing the company's competitiveness in the health food sector. This move is in line with the company's strategic planning to develop the health industry and lay a foundation for the company's continuous growth.
Related Articles

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families






